Lyrica Capsule 50 mg (Pregabalin)

Adult dose

This medication should be taken by dividing the total daily dosage into two doses, with or without food. 1. Neuropathic pain 1) Peripheral neuropathic pain: - Starting dose of 150 mg per day - Possible dosage increase to 300 mg per day after 3 to 7 days - If necessary, can increase up to a maximum of 600 mg per day every 7 days 2) Central neuropathic pain: -

Child dose

Safety and efficacy data is insufficient for children under 12 years of age and adolescents aged 12-17, so administration is not recommended.

This medication may increase the risk of suicidal thoughts or behaviors, so careful observation for mood changes or unusual behaviors should be conducted during treatment. Patients allergic to any ingredients in this medication or those with certain genetic lactose intolerance should not take it. Diabetic patients should be cautious as weight gain after taking this medication may require adjustments in their blood glucose control medications. If allergic reactions like angioedema occur, discontinue use immediately and consult medical personnel. Elderly patients should be careful as this medication may increase dizziness or drowsiness, leading to a higher risk of falls or accidents. Blurred vision or changes in vision may occur during treatment; if symptoms persist, consult a doctor. Sudden discontinuation of this medication can result in withdrawal symptoms such as insomnia, headache, and anxiety, so it should be tapered off gradually under medical supervision. Patients with a history of drug abuse should take special care as this medication carries a risk of abuse. Patients with impaired renal function may require dosage adjustments for this medication. Patients with heart diseases should proceed carefully as there may be a risk of congestive heart failure when taking this medication. Taking this medication with central nervous system depressants may increase the risk of drowsiness or respiratory depression, so caution is advised. In early pregnancy, there is a risk of fetal malformation, so this medication should be avoided during pregnancy, and women of childbearing age should use effective contraception. Breastfeeding women should consider stopping breastfeeding or discontinuing this medication as it may be excreted in breast milk. Dizziness and drowsiness may occur during treatment; therefore, driving or operating dangerous machinery should be avoided until symptoms are assessed. In case of overdose, symptoms such as confusion, drowsiness, and depression may occur, and treatment such as hemodialysis may be necessary if needed. This medication should be kept out of reach of children, and transferring to another container should be avoided.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in oral/eye mucous membranes, difficulty or shortness of breath, asthma attacks, respiratory abnormalities with cough and fever, yellowing of the skin or eyes (jaundice), profound lethargy, sudden and severe headache, lightning headache, seizures, altered consciousness, visual disturbances, paralysis, urination issues.

Mild side effects

• Confusion
• depression
• dizziness
• drowsiness
• dry mouth
• swelling
• vertigo
• vomiting
• peripheral edema
• tremor

This medication should be stored in a tightly closed container to protect it from air and moisture. The recommended storage temperature is between 15 to 30 degrees Celsius.

Appearance

A white capsule with a white upper part and a black line, containing a white or light yellow powder.

Package unit

30 capsules/bottle